Preliminary results of the Norwegian doxazosin postmarketing surveillance study: A twelveweek experience
- 1 January 1991
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 121 (1) , 260-267
- https://doi.org/10.1016/0002-8703(91)90855-c
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Comparison of the effects of doxazosin and atenolol on blood pressure and blood lipids: A one-year, double-blind study in 228 hypertensive patientsAmerican Heart Journal, 1988
- Drug treatment of mild hypertension to reduce the risk of CHD: Is it worth-while?Statistics in Medicine, 1988
- Strategies to reduce risk factors in hypertensive patients who smokeAmerican Heart Journal, 1988
- Coronary heart disease: Epidemiology of smoking and intervention studies of smokingAmerican Heart Journal, 1988
- Pharmacokinetic overview of doxazosinThe American Journal of Cardiology, 1987
- A 24‐week Multicenter Double‐blind Study of Doxazosin and Hydrochlorothiazide in Patients with Mild to Moderate Essential HypertensionActa Medica Scandinavica, 1987
- A long‐term double‐blind comparison of doxazosin and atenolol in patients with mild to moderate essential hypertension.British Journal of Clinical Pharmacology, 1986
- Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.British Journal of Clinical Pharmacology, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- EFFECT OF DIET AND SMOKING INTERVENTION ON THE INCIDENCE OF CORONARY HEART DISEASEThe Lancet, 1981